Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Cachope

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 31, 2012
Functional diversity on synaptic plasticity mediated by endocannabinoidsRoger Cachope
Frontiers in Behavioral Neuroscience|June 7, 2014
Local control of striatal dopamine releaseRoger Cachope, Joseph F Cheer
Brain Research|July 10, 2012
Two independent forms of activity-dependent potentiation regulate electrical transmission at mixed synapses on the Mauthner cellRoger Cachope, Alberto E Pereda
Neuroscience|July 4, 2020
Regulatory Roles of Metabotropic Glutamate Receptors on Synaptic Communication Mediated by Gap JunctionsRoger Cachope, Alberto E Pereda
Journal of Neurophysiology|May 29, 2015
Opioids potentiate electrical transmission at mixed synapses on the Mauthner cellRoger Cachope, Alberto E Pereda
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 6, 2013
Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone?Erik B Oleson, Roger Cachope, Aurelie Fitoussi, et al.
Neuron|December 21, 2007
Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoidsRoger Cachope, Ken Mackie, Antoine Triller, et al.
Journal of Neurochemistry|August 12, 2016
Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbensAdem Can, Douglas O Frost, Roger Cachope, et al.
Pharmacology Research & Perspectives|October 4, 2017
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's diseaseDaniel S Whittaker, Huei-Bin Wang, Dawn H Loh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 7, 2019
Enhanced striatopallidal gamma-aminobutyric acid (GABA)<sub>A</sub> receptor transmission in mouse models of huntington's diseaseTamara Perez-Rosello, Simon Gelman, Geoffrey Tombaugh, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 31, 2012
Functional diversity on synaptic plasticity mediated by endocannabinoidsRoger Cachope
Frontiers in Behavioral Neuroscience|June 7, 2014
Local control of striatal dopamine releaseRoger Cachope, Joseph F Cheer
Brain Research|July 10, 2012
Two independent forms of activity-dependent potentiation regulate electrical transmission at mixed synapses on the Mauthner cellRoger Cachope, Alberto E Pereda
Neuroscience|July 4, 2020
Regulatory Roles of Metabotropic Glutamate Receptors on Synaptic Communication Mediated by Gap JunctionsRoger Cachope, Alberto E Pereda
Journal of Neurophysiology|May 29, 2015
Opioids potentiate electrical transmission at mixed synapses on the Mauthner cellRoger Cachope, Alberto E Pereda
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 6, 2013
Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone?Erik B Oleson, Roger Cachope, Aurelie Fitoussi, et al.
Neuron|December 21, 2007
Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoidsRoger Cachope, Ken Mackie, Antoine Triller, et al.
Journal of Neurochemistry|August 12, 2016
Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbensAdem Can, Douglas O Frost, Roger Cachope, et al.
Pharmacology Research & Perspectives|October 4, 2017
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's diseaseDaniel S Whittaker, Huei-Bin Wang, Dawn H Loh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 7, 2019
Enhanced striatopallidal gamma-aminobutyric acid (GABA)<sub>A</sub> receptor transmission in mouse models of huntington's diseaseTamara Perez-Rosello, Simon Gelman, Geoffrey Tombaugh, et al.
Pageof 4